Abstract 4728: Biochemical and genomic approaches for high throughput drug discovery in chromatin remodeling research
Authors: Sun Lu , Willis Hannah , Marunde Matthew R. , Kumary Vishnu U. , Meiners Matthew J. , Gopinath Saarang , Burg Jonathan M. , Venters Bryan J. , Hickman Allison , Sun Zu-Wen , Cowles Martis W. , Esteve Pierre , Chin Hang Gyeong , Ponnaluri Chaithanya , Pradhan Sriharsa , Keogh Michael-Christopher 
Published: April 2023

Abstract
Chromatin remodeling is mediated by ATP-dependent enzymes that play key roles regulating gene expression and genome replication/repair. Aberrant nucleosome organization from dysregulated chromatin remodeling can severely alter chromatin accessibility and disrupt these important processes, thereby driving various cancers. Remarkably, nearly 20% of all human cancers contain mutations in subunits from the SWI/SNF family of chromatin remodeling complexes, making them of great interest to basic research and therapeutic intervention. In vitro studies on the remodeling enzymes (and their multi-subunit complexes) are challenging, partially due to the strong preference for nucleosome-based substrates (the physiological target of these enzymes). We have created the EpiDyne® nucleosome portfolio to examine chromatin remodeler activity in biochemical assays, and here present the development of novel readouts (-PicoGreenTM and -TR-FRET). These nonradioactive plate-based assays are automation adaptable, ready for high-throughput inhibitor screening, and can be customized for various remodeling enzymes that exhibit preferences in nucleosome composition (e.g. histone type or DNA linker length).For parallel in vivo studies we note that genome-wide remodeler localization and open chromatin mapping are fundamental for understanding the function/activity of these enzymes in cancer development and inhibitor response. However, traditional genomic approaches have significant issues: e.g. ChIP-seq is unable to effectively map ATPases without heavily modified high-noise protocols; while ATAC-seq to map open regions cannot deal with cross-linking that could stabilize transient states on interest. To this end, we have optimized the CUTANA™ CUT&RUN approach to efficiently capture the localization of all major classes of chromatin remodelers with high signal to background. We have also adopted NicE-seq for chromatin accessibility profiling in cross-linked material. As complementary tools to the EpiDyne platform, CUT&RUN and NicE-seq facilitate epigenomic research on chromatin remodelers in cancer therapeutic intervention. Keywords: Chromatin Remodeling, EpiDyne, Nucleosome repositioning, high-throughput screening (HTS), CUTANA™ CUT&RUN, NicE-seq
Citation Format: Lu Sun, Hannah Willis, Matthew R. Marunde, Vishnu U. Kumary, Matthew J. Meiners, Saarang Gopinath, Jonathan M. Burg, Bryan J. Venters, Allison Hickman, Zu-Wen Sun, Martis W. Cowles, Pierre Esteve, Hang Gyeong Chin, Chaithanya Ponnaluri, Sriharsa Pradhan, Michael-Christopher Keogh. Biochemical and genomic approaches for high throughput drug discovery in chromatin remodeling research. [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 4728.